Pharming Group NV (PHAR)
11.79
-0.11
(-0.92%)
USD |
NASDAQ |
Oct 27, 16:00
11.89
+0.10
(+0.85%)
After-Hours: 20:00
Pharming Group Price to Book Value : 3.247 for Oct. 27, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 26, 2026 | 3.277 |
| October 23, 2026 | 3.084 |
| October 22, 2026 | 2.938 |
| October 21, 2026 | 2.657 |
| October 20, 2026 | 2.685 |
| October 19, 2026 | 2.509 |
| October 16, 2026 | 2.577 |
| October 15, 2026 | 2.652 |
| October 14, 2026 | 2.654 |
| October 13, 2026 | 2.600 |
| October 12, 2026 | 2.646 |
| October 09, 2026 | 2.696 |
| October 08, 2026 | 2.624 |
| October 07, 2026 | 2.657 |
| October 06, 2026 | 2.666 |
| October 05, 2026 | 2.699 |
| October 02, 2026 | 2.685 |
| October 01, 2026 | 2.740 |
| September 30, 2026 | 2.751 |
| September 29, 2026 | 2.756 |
| September 28, 2026 | 2.897 |
| September 25, 2026 | 2.880 |
| September 24, 2026 | 2.875 |
| September 23, 2026 | 2.966 |
| September 22, 2026 | 3.101 |
| Date | Value |
|---|---|
| September 21, 2026 | 2.977 |
| September 18, 2026 | 2.905 |
| September 17, 2026 | 2.968 |
| September 16, 2026 | 2.919 |
| September 15, 2026 | 2.905 |
| September 14, 2026 | 2.980 |
| September 11, 2026 | 3.087 |
| September 10, 2026 | 2.975 |
| September 09, 2026 | 3.021 |
| September 08, 2026 | 3.167 |
| September 04, 2026 | 3.092 |
| September 03, 2026 | 3.156 |
| September 02, 2026 | 3.084 |
| September 01, 2026 | 3.059 |
| August 31, 2026 | 3.161 |
| August 28, 2026 | 3.222 |
| August 27, 2026 | 3.244 |
| August 26, 2026 | 3.291 |
| August 25, 2026 | 3.241 |
| August 24, 2026 | 3.156 |
| August 21, 2026 | 3.263 |
| August 20, 2026 | 3.216 |
| August 19, 2026 | 3.263 |
| August 18, 2026 | 3.280 |
| August 17, 2026 | 3.247 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ProQR Therapeutics NV | 2.073 |
| NewAmsterdam Pharma Co. NV | 3.820 |
| argenx SE | -- |
| Nektar Therapeutics | 1.435 |
| uniQure NV | 5.195 |
Price to Book Value Related Metrics
| PE Ratio | 94.85 |
| PS Ratio | 2.370 |
| Price to Free Cash Flow | 33.78 |
| Price | 11.79 |
| Earnings Yield | 1.05% |
| Market Cap | 834.47M |
| Operating PE Ratio | 38.83 |
| Normalized PE Ratio | 52.92 |